Navigation Links
Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)
Date:6/22/2009

Adaptive trials leader and CDRH regulators join to create Bayesian trial design and analysis software standard

CAMBRIDGE, Mass., June 22 /PRNewswire/ -- Cytel Inc., a leading provider of biostatistical software and clinical trial design services, today announced the signing of a Cooperative Research And Development Agreement (CRADA) with the Center for Devices and Radiological Health (CDRH), a division of the United States Food and Drug Administration (FDA).

The agreement acknowledges that despite the CDRH's encouragement of clinical study sponsors to employ Bayesian-based device trials, no validated, easy-to-use design or analysis software has emerged. The goal of the CDRH collaboration with Cytel is to eliminate the productivity-sapping cycles of developing and validating ad-hoc methodologies with a reliable and easily-learned standard software package for both trial sponsors and regulators.

Gerry W. Gray, Ph.D., is the Principal Investigator for the FDA. Nitin Patel, Ph.D., Cytel Co-Founder, Chairman, and Chief Technology Officer, will lead the development effort as Cytel Principal Investigator.

Dr. Patel commented, "We are honored that CDRH chose Cytel as their partner for developing validated, documented, and commercially available Bayesian software. The CRADA is completely aligned with our vision of implementing innovative device and drug development approaches by combining high-quality software and knowledge-intensive services. Creation of these best-in-class Bayesian tools is a crucial initiative in our efforts to help the clinical development community to reduce time-to-market, cut costs, and improve portfolio returns."

The CRADA Research Plan Abstract

The Center for Devices and Radiological Health (CDRH) at the FDA encourages sponsors to use innovative Bayesian designs for clinical trials involving device products. The Bayesian approach provides a natural way to combine prior evidence with current data. Moreover for devices, good prior information often exists, as for example in studies of previous generations of the same device. At the present time the software tools that are needed for designing and analyzing Bayesian clinical trials are not available in any validated, commercially viable, easy to use software package. Thus, execution of Bayesian clinical trials requires considerable expertise in both Bayesian methodology and in computer programming.

Further, CDRH statisticians usually need to write special programs to verify the operating characteristics of each Bayesian submission separately. This is an inhibiting factor and puts considerable burden on sponsors in carrying out the simulations that are submitted to CDRH and on CDRH statisticians in validating what is submitted.

About Cytel

Cytel Inc. is a leading provider of specialized statistical software and clinical trial services for the biopharmaceutical, medical device, academic and government research markets.

Cytel pioneered the statistical and computational science of adaptive clinical trials and has designed more validated adaptive trials than any other service provider. Cytel serves trial sponsors with innovative tools, training and consultation to increase the return on investment in clinical development.


'/>"/>
SOURCE Cytel Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
2. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
3. Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
4. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
5. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
6. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
7. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
8. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
9. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
10. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
11. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County ... its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The ... disinfection robot that uses UVC light energy to kill deadly pathogens such as C. ... Tru-D SmartUVC ... Tru-D in action in ...
(Date:8/2/2017)... 2017 CaryRx, a next-generation full-service pharmacy, has announced ... patients in the Washington D.C. metropolitan ... providing delivery of medications through the convenience of its patient-friendly ... delivered within one hour to any location in D.C. ... this invaluable service to Washington D.C. ," says ...
(Date:7/31/2017)... , July 31, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan by Crain,s Detroit Business ... and public companies by three-year revenue growth. This year,s edition ... To view the complete list, visit crainsdetroit.com/awards/fast_50/2017 ... is an incredible triumph," said Phil Hagerman , CEO ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Dr. Charles W. Grimsley’s ... ($15.99, paperback, 9781498497626; $7.99, eBook, 9781498497633) focuses on the treatment of veterans ... and achieve forgiveness, through a progressive journey toward healing. This book will help ...
(Date:8/17/2017)... ... August 17, 2017 , ... Inc. Magazine Unveils 36th ... No. 132 with Three-Year Sales Growth of 3,004.8% , NEW YORK, August 16, 2017 ... 5000, the most prestigious ranking of the nation's fastest-growing private companies. The list represents ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC recently ... is a member of the firm’s Commercial Litigation and Employment Law groups. , Ms. ... of knowledge in matters of employment litigation, commercial litigation and business disputes. Her experience ...
(Date:8/17/2017)... ... August 17, 2017 , ... Centrifugation is more than just spinning. ... that we can no longer do without. And just like a car, there are ... , In this webinar, attendees will learn about the most important safety aspects while ...
(Date:8/17/2017)... ... August 17, 2017 , ... A recent report indicates that ... industry in 2016 cited deficiencies in data integrity. The FDA outlines their expectations for ... , Presented as part of the Beckman Coulter Life Sciences Virtual Trade ...
Breaking Medicine News(10 mins):